Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Allosteric AKT inhibitors for use in the treatment of Hereditary Hemorrhagic Telangiectasia

Allosteric AKT inhibitors for use in the treatment of Hereditary Hemorrhagic Telangiectasia

US Patent 12466839 · Granted Nov 11, 2025

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Therapy for promoting cell growth2019
Combination therapy for treatment of patients with neurological disorders and ce2016
Therapy for promoting cell growth2016
Combination therapy for treatment of patients with neurological disorders and ce2014
Methods and compositions for assessing acute rejection2010
Packaging container1987